Edap Tms (EDAP) PT Set at $7.00 by HC Wainwright

Share on StockTwits

Edap Tms (NASDAQ:EDAP) received a $7.00 target price from investment analysts at HC Wainwright in a research note issued on Friday, TipRanks reports. The firm presently has a “buy” rating on the medical equipment provider’s stock. HC Wainwright’s target price would suggest a potential upside of 105.28% from the stock’s current price.

Other equities research analysts have also recently issued reports about the stock. Zacks Investment Research raised shares of Edap Tms from a “hold” rating to a “strong-buy” rating and set a $5.50 target price on the stock in a research report on Tuesday, April 9th. ValuEngine raised shares of Edap Tms from a “hold” rating to a “buy” rating in a research report on Wednesday, April 3rd. Finally, TheStreet raised shares of Edap Tms from a “c” rating to a “b-” rating in a research report on Wednesday, May 8th.

Shares of Edap Tms stock traded down $0.17 during mid-day trading on Friday, hitting $3.41. 205,877 shares of the stock were exchanged, compared to its average volume of 201,242. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.40 and a quick ratio of 1.97. Edap Tms has a twelve month low of $1.35 and a twelve month high of $5.42. The stock has a market capitalization of $98.88 million, a P/E ratio of 170.50 and a beta of 1.90.

Edap Tms (NASDAQ:EDAP) last released its earnings results on Wednesday, May 15th. The medical equipment provider reported $0.01 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.01. Edap Tms had a negative net margin of 0.36% and a negative return on equity of 0.85%. The business had revenue of $11.50 million for the quarter, compared to analysts’ expectations of $13.25 million. As a group, analysts forecast that Edap Tms will post 0.11 EPS for the current year.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Naples Global Advisors LLC acquired a new stake in shares of Edap Tms in the fourth quarter worth approximately $31,000. Commonwealth Equity Services LLC boosted its position in shares of Edap Tms by 27.0% in the first quarter. Commonwealth Equity Services LLC now owns 23,500 shares of the medical equipment provider’s stock worth $70,000 after acquiring an additional 5,000 shares during the last quarter. Hilton Capital Management LLC acquired a new stake in shares of Edap Tms in the first quarter worth approximately $75,000. Finally, Fosun International Ltd lifted its position in Edap Tms by 46.0% during the fourth quarter. Fosun International Ltd now owns 249,143 shares of the medical equipment provider’s stock valued at $421,000 after buying an additional 78,516 shares in the last quarter. 10.07% of the stock is currently owned by institutional investors and hedge funds.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).

Recommended Story: Equity Income

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.